Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Vartrace® BRAF Panel
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
NuProbe
Type:
Laboratory Developed Test
Related tests:
‹
CNV+ Breast Cancer NGS Panel
VarMap™ Pan-Cancer NGS Panel
VarTrace® MSI Assay
Vartrace® AML Panel
Vartrace® EGFR Panel
CNV+ Breast Cancer NGS Panel
VarMap™ Pan-Cancer NGS Panel
VarTrace® MSI Assay
Vartrace® AML Panel
Vartrace® EGFR Panel
›
Details
Evidence
News
NuProbe’s VarTrace™ BRAF Assay detects and quantifies actionable BRAF mutations including V600E/K/R, L597P/Q/R/S, and K601E down to 0.1% VAF, requiring 10 – 100 ng cell-free DNA from blood plasma or 10 – 1000 ng DNA from tissue biopsy.
Cancer:
Colorectal Cancer, Melanoma, Thyroid Gland Papillary Carcinoma
Gene:
BRAF (B-raf proto-oncogene)
BRAF (B-raf proto-oncogene)
Drug:
Zelboraf (vemurafenib)
Method:
PCR
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login